138 related articles for article (PubMed ID: 12608463)
1. Effects of non-steroidal anti-inflammatory drugs on the methotrexate transport in rat small intestine.
Sosogi A; Gao F; Tomimatsu T; Hirata K; Horie T
Scand J Gastroenterol; 2003 Jan; 38(1):43-9. PubMed ID: 12608463
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs affect the methotrexate transport in IEC-6 cells.
Sosogi A; Gao F; Tomimatsu T; Hirata K; Horie T
Life Sci; 2003 Jun; 73(4):437-46. PubMed ID: 12759138
[TBL] [Abstract][Full Text] [Related]
3. Fluorescein-methotrexate transport in brush border membrane vesicles from rat small intestine.
Li T; Tomimatsu T; Ito K; Horie T
Life Sci; 2003 Oct; 73(20):2631-9. PubMed ID: 12967687
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
Iwaki M; Shimada H; Irino Y; Take M; Egashira S
Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
[TBL] [Abstract][Full Text] [Related]
5. Binding and transport of methotrexate and its derivative, MX-68, across the brush-border membrane in rat kidney.
Han YH; Kato Y; Sugiyama Y
Biopharm Drug Dispos; 1999 Nov; 20(8):361-7. PubMed ID: 10870092
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
7. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil.
Tomimatsu T; Horie T
Chem Biol Interact; 2005 Aug; 155(3):129-39. PubMed ID: 15996645
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter.
Nakai Y; Inoue K; Abe N; Hatakeyama M; Ohta KY; Otagiri M; Hayashi Y; Yuasa H
J Pharmacol Exp Ther; 2007 Aug; 322(2):469-76. PubMed ID: 17475902
[TBL] [Abstract][Full Text] [Related]
9. Stereoselectivity of the folate transporter in rabbit small intestine: studies with amethopterin enantiomers.
Itoh T; Ono K; Koido KI; Li YH; Yamada H
Chirality; 2001; 13(3):164-9. PubMed ID: 11270327
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of transport of fluoresceinated methotrexate in rat small intestine.
Nagakubo J; Tomimatsu T; Kitajima M; Takayama H; Aimi N; Horie T
Life Sci; 2001 Jul; 69(7):739-47. PubMed ID: 11487087
[TBL] [Abstract][Full Text] [Related]
11. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Takeuchi K; Yokota A; Tanaka A; Takahira Y
Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
[TBL] [Abstract][Full Text] [Related]
12. Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.
Yokooji T; Mori N; Murakami T
J Pharm Pharmacol; 2009 Jul; 61(7):911-8. PubMed ID: 19589233
[TBL] [Abstract][Full Text] [Related]
13. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport.
El-Sheikh AA; van den Heuvel JJ; Koenderink JB; Russel FG
J Pharmacol Exp Ther; 2007 Jan; 320(1):229-35. PubMed ID: 17005917
[TBL] [Abstract][Full Text] [Related]
14. Vitamin A protects the small intestine from methotrexate-induced damage in rats.
Tsurui K; Kosakai Y; Horie T; Awazu S
J Pharmacol Exp Ther; 1990 Jun; 253(3):1278-84. PubMed ID: 2359028
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of methotrexate-induced gastrointestinal toxicity by non-steroidal anti-inflammatory drugs (NSAIDs) and vincristine.
Badr MZ; Chen TS
Toxicology; 1985 Mar; 34(4):333-40. PubMed ID: 3992591
[TBL] [Abstract][Full Text] [Related]
16. The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.
Visentin M; Unal ES; Zhao R; Goldman ID
Cancer Chemother Pharmacol; 2013 Sep; 72(3):597-606. PubMed ID: 23881211
[TBL] [Abstract][Full Text] [Related]
17. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
18. Role of sodium ion in transport of folic acid in the small intestine.
Zimmerman J; Selhub J; Rosenberg IH
Am J Physiol; 1986 Aug; 251(2 Pt 1):G218-22. PubMed ID: 2426969
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions in intestinal transport of folic acid and methotrexate. Further evidence for the heterogeneity of folate transport in the human small intestine.
Zimmerman J
Biochem Pharmacol; 1992 Nov; 44(9):1839-42. PubMed ID: 1360212
[TBL] [Abstract][Full Text] [Related]
20. Is intestinal peptide transport energized by a proton gradient?
Ganapathy ; Leibach FH
Am J Physiol; 1985 Aug; 249(2 Pt 1):G153-60. PubMed ID: 2992286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
